4//SEC Filing
Grimes Scott D. 4
Accession 0001666071-22-000110
CIK 0001666071other
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 4:38 PM ET
Size
7.1 KB
Accession
0001666071-22-000110
Insider Transaction Report
Form 4
Cardlytics, Inc.CDLX
Grimes Scott D.
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2022-08-05$15.19/sh−9,257$140,614→ 238,594 total
Holdings
- 55,832(indirect: See Footnote)
Common Stock
- 53,112(indirect: See Footnote)
Common Stock
Footnotes (5)
- [F1]Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on June 9, 2022.
- [F2]The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $14.87 to $15.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) to this Form 4.
- [F3]Includes 291 shares of Common Stock acquired under the Issuer's Employee Stock Purchase Plan.
- [F4]The reportable securities are held by the UTMA Custodial account fbo Pierce Grimes.
- [F5]The reportable securities are held by the 2013 Scott Grimes GRAT UAD.
Documents
Issuer
Cardlytics, Inc.
CIK 0001666071
Entity typeother
Related Parties
1- filerCIK 0001617486
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 4:38 PM ET
- Size
- 7.1 KB